قالب وردپرس درنا توس
Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ US https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ House Democrats are ready to jam GOP on voting the drug

House Democrats are ready to jam GOP on voting the drug




  Greg Walden "title =" Greg Walden "/> </source></source></source></source></picture></div><figcaption>
<p>
                " It does not have to be this way, "says Rep. Rep. Greg Walden." But they are just waiting to cut TV ads. "Zach Gibson / Getty Images </p>
</figcaption></figure>
</p></div>
<p>  House Democrats on Thursday are set to make their first major step toward lowering drug prices, but not before they make life difficult for <b><i> </i></b>  Republicans who help them get there. </p>
<p>  The House <b> </b>  has <b><i> </i></b>  voted on three biparties of drug pricing combined by Democratic leaders in a range of measures aimed at reverse the Trump management efforts to weaken Obamacare The move is likely to force most Republicans to dip into the package and record as efforts to control drug costs. Obamacare mixing drug pricing will also effectively kill the chances of the Senate-controlled Senate law. </p><div><script async src=

The Story Continues Below

The tactics were angry with the The Republicans spent months negotiating with the laws that fell to pharmaceutical companies, and even prompted the whistle from mediocrity Democrats were eager to show a uniformity of bipartisance to a top priority in health care.

"I'm not very happy," says Rep Buddy Carter (R-Ga.), That the bill forbidding the abilities of generic drugs to block competitors are included in the package. "They know we can not be able to support it, and for them to put that in there I think is just a poor policy."

House Democrats defend maneuvers as a budget need. The trio of drug pricing charges collectively collects approximately $ 4 billion over a decade, making more important offsets for Obamacare bills to call for larger federal spending to raise health insurance insurance markets and reversal imposed by the administration.

No drug pricing measures are expected to lower the cost of drugs. But they will prevent the anticompetitive behavior of pharmaceutical companies and address an issue that shows polls resonating with voters of all political groups.

Energy and Commercial Committees Republicans unanimously backed up in the progress of floor bills last month have not tried to encourage Democratic leaders to win stand-alone who voted for drug pricing measures at a Tuesday night Tuesday meeting – and accused them of sacrificing great law to score political points.

"It does not have to be this way," Rep. Greg Walden (R-Ore.), Member of the committee's rank. "But they're just waiting to cut TV ads."

Vibrant feelings may be subject to health policy priorities such as protecting patients from "surprises" medical charges and a series of major health care policy extensions. [19659005] "For Republicans, they say we've done it once, but we need to trust you again," says Rodney Whitlock, a health advisor and former GOP congressional aide. "This is the first time – if there is a second time, there will be no third."

The inclusion of the provisions of Obamacare does everything but surely the Senate will ignore the combined package, which leaves the steps pricing drug deficit.

to revive these measures later this year and roll them to the broader passage law, a person familiar with the thought said. putting itself in a stronger ne got the position in the Senate when they do two parties at work, "Whitlock says." It effectively says that they will not be. "

Democratic leaders have graduated the political benefits of making a health care package prohibit those risks, according to people familiar with the strategy, especially on an issue made by the party on its platform before the 2020 election.

The Democrats have found that a handful of Republicans who want to undergo Trump's health care management. Four moderate Republicans last week broke ranks in law reversing Trump guides encouraging states to dodge key Obamacare patient protection.


Source link